Rajni Brar – Beta Drugs Limited
View Detailed Executive Profile →Professional Overview
- Rajni Brar serves as the Company Secretary and Compliance Officer at Beta Drugs Ltd., reflecting her significant role in the organization's governance and regulatory adherence.
- She has garnered experience in the pharmaceutical industry through her position at Beta Drugs Ltd., contributing to the company's compliance with legal standards and corporate governance practices.
- Rajni is a member of the Institute of Company Secretaries of India, indicating her professional credentials and commitment to the field of company secretarial practices.
- Her responsibilities include ensuring that Beta Drugs Ltd. operates in accordance with corporate laws and regulations, which is critical for maintaining the company's integrity and reputation in the market.
- Rajni has been part of Beta Drugs Ltd., a member of the Adley Group, which manufactures a wide range of pharmaceutical products, contributing to a major player in the industry.
- She maintains connections within her professional network, demonstrating her engagement with peers and her influence in the field of corporate compliance.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| ASTER DRUGS AND PHARMACEUTICALS LIMITED | Company Secretary | Jun 2016 – Mar 2017 |
| BDL - Beta Drugs Ltd. | panchkula | Jul 2017 |
| Punjab State Industrial Development Corporation | Company Secretary | Jul 2014 – Dec 2015 |
| Him Teknoforge Ltd | Company Secretary | Jan 2010 – Jul 2014 |
| Adley Lab Limited | Director | 28 Jun 2019 – Present |
| Adley Lifesciences Private Limited | Director | 25 May 2016 – Present |
| Kedge Pharmacia (India) Private Limited | Director | 24 Jul 2008 – Present |
| Beta Research Private Limited | Director | 22 Jun 2022 – Present |
| Adley Formulations Private Limited | Whole-time director | 09 Oct 2018 – Present |
| Adley Resorts Private Limited | Director | 08 Dec 2009 – Present |
| Bt Associates Private Limited | Director | 01 Jun 2016 – Present |
| Beta Drugs Limited | Managing Director | 01 Aug 2014 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| L24230HP2005PLC028969 | Beta Drugs Limited | Managing Director | 01 Aug 2014 |
| U24231PB1992PLC051220 | Adley Lab Limited | Director | 28 Jun 2019 |
| U24233HR2008PTC038185 | Kedge Pharmacia (India) Private Limited | Director | 24 Jul 2008 |
| U24303HR2018PTC076347 | Adley Formulations Private Limited | Whole-time director | 09 Oct 2018 |
| U24303HR2022PTC104598 | Beta Research Private Limited | Director | 22 Jun 2022 |
| U36998HR2016PTC064275 | Adley Lifesciences Private Limited | Director | 25 May 2016 |
| U51909HR2016PTC064363 | Bt Associates Private Limited | Director | 01 Jun 2016 |
| U55101CH2009PTC031918 | Adley Resorts Private Limited | Director | 08 Dec 2009 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Beta Drugs Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Rajni Brar's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Beta Drugs Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)